From Wikipedia, the free encyclopediaJump to navigation Jump to search
This article needs more links to other articles to help integrate it into the encyclopedia. Please help improve this article by adding links that are relevant to the context within the existing text. (November 2017) (Learn how and when to remove this template message)
|Chemical and physical data|
|Molar mass||455.418 g/mol g·mol−1|
|3D model (JSmol)|
DR-4485 is a compound which acts as a potent and selective antagonist for the 5-HT7 receptor, with good oral bioavailability. It has been used to research the function of this still comparatively little studied serotonin receptor subtype.
- Kikuchi C, Suzuki H, Hiranuma T, Koyama M. New tetrahydrobenzindoles as potent and selective 5-HT(7) antagonists with increased In vitro metabolic stability. Bioorganic & Medicinal Chemistry Letters. 2003 Jan 6;13(1):61-4. PMID 12467617
- Medina RA, Sallander J, Benhamú B, Porras E, Campillo M, Pardo L, López-Rodríguez ML. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity. Journal of Medicinal Chemistry. 2009 Apr 23;52(8):2384-92. DOI 10.1021/jm8014553. PMID 19326916
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|
Retrieved from "https://en.wikipedia.org/w/index.php?title=DR-4485&oldid=810230806"